A prediction model based on clinical and histological features for predicting recurrence in patients with stage I-II endometrial cancer after surgical treatment-Reference-Cited by-同舟云学术

A prediction model based on clinical and histological features for predicting recurrence in patients with stage I-II endometrial cancer after surgical treatment

Published:2022-02 Issue: Volume:56 Page:151861
ISSN:1092-9134
Container-title:Annals of Diagnostic Pathology
language:en
Short-container-title:Annals of Diagnostic Pathology

Author:

Song Weiwei,Zhao Yinling

Publisher

Elsevier BV

Subject

General Medicine,Pathology and Forensic Medicine

Reference40 articles.

1. Endometrial cancer: mapping the global landscape of research;Bruggmann;J Transl Med,2020

2. Comparative performance of the 2009 international federation of gynecology and obstetrics’ staging system for uterine corpus cancer;Lewin;Obstet Gynecol,2010

3. Carcinoma of the corpus uteri. FIGO 26th annual report on the results of treatment in gynecological Cancer;Creasman;Int J Gynaecol Obstet,2006

4. Baseline risk of recurrence in stage I-II endometrial carcinoma;Sasada;J Gynecol Oncol,2018

5. Factors predicting recurrent endometrial cancer;Huijgens;Facts Views Vis Obgyn,2013

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association of insulin-like growth factor II mrna-binding protein 3 (IMP3) expression with prognostic and morphological factors in endometrial cancer;Revista Brasileira de Ginecologia e Obstetrícia;2024

2. The prognostic value of P53 index in predicting the recurrence of early low‐risk endometrial cancer;Journal of Obstetrics and Gynaecology Research;2023-07-27

3. The interplay of sex steroid hormones and microRNAs in endometrial cancer: current understanding and future directions;Frontiers in Endocrinology;2023-04-21